Vortex enhanced liquid chromatography for HbA1c monitoring based diabetes management in a globalized setting
VortexLC aims to develop a cost-effective point-of-care device for accurate HbA1c quantification in diabetes patients, utilizing advanced polymer columns for improved analysis and mass manufacturing.
Projectdetails
Introduction
Diabetes is one of the main health risks today with near pandemic dimensions, causing blindness, kidney failures, stroke, and heart attack. This condition gives rise to very high health care costs (25% in the US) and reduces the quality of life for around 500 million people worldwide.
Importance of HbA1c Measurement
The level of hemoglobin A1c (HbA1c) is used to assess long-term glycemic control and is the best predictor for the risk of developing chronic complications of diabetes. It also aids in the appropriate follow-up of patients.
Limitations of Current Methods
The golden standard is an expert laboratory HPLC method focusing on HbA1c quantification. However, this method has limitations when other relevant hemoglobin variants need to be detected. For approximately 7% of the world’s population who are carriers of such hemoglobin variants, current methods lead to:
- Under-estimation of the HbA1c fraction
- Over-estimation of the HbA1c fraction
- Non-estimation of the HbA1c fraction
VortexLC Solution
VortexLC aims to improve the quality of the analysis to provide an instant full picture of the health status of diabetes patients. It will also produce a cost-effective point-of-care device.
Advantages of Vortex Flows
The use of vortex flows renders the approach compatible with mass manufacturing of plastic pillar array columns. These columns are:
- Much cheaper than commonly used packed bed columns
- Capable of achieving higher separation performances
Manufacturing Process
The polymer columns will be fabricated using several advanced techniques:
- UV-nanoimprint lithography
- Plasma technology to make them porous and add a chromatographic coating
- Lamination to close the column
All these processes can be scaled to roll-to-roll industrial manufacturing.
Instrumentation and Testing
The columns will be embedded in an instrument that allows for:
- Integrated sample preparation
- Miniaturized UV absorption and SERS detection
This setup will enable both quantification and identification of analytes.
Project Goals
In the project, a low footprint demonstrator of the novel system and columns will be built and tested with:
- First synthetic samples
- Next, human blood samples
The goal is to quantify HbA1c and its genetic variants.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.014.375 |
Totale projectbegroting | € 3.014.375 |
Tijdlijn
Startdatum | 1-3-2022 |
Einddatum | 28-2-2026 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- VRIJE UNIVERSITEIT BRUSSELpenvoerder
- "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
- JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
- COATING PLASMA INNOVATION SAS
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated DiabetesThis project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications. | EIC Pathfinder | € 3.885.462 | 2023 | Details |
In-vessel implantable smart sensing device for personalised medicineThe IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations. | EIC Pathfinder | € 4.158.610 | 2023 | Details |
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabetes
This project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications.
In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Column with AC-EOF Induced Vortices for HPLCThe project aims to enhance blood analysis efficiency by integrating vortex mixing in HPLC columns, enabling faster separations for improved diagnostics, including diabetes monitoring. | ERC Proof of... | € 150.000 | 2022 | Details |
The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scaleDeveloping a non-invasive glucose monitoring device to improve diabetes management and prevent onset for over 2 billion people through EIC blended finance support. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Metal-Organic-Framework Kinetic Array for Diabetes DetectionThis project aims to develop a novel sensor using metal-organic frameworks to selectively detect volatile organic compounds in breath for non-invasive diabetes diagnosis. | ERC Proof of... | € 150.000 | 2024 | Details |
AFIDIHet project ontwikkelt een betaalbare, minimaal invasieve CGM-sensor voor diabetespatiënten, die data veilig beheert en artsen toegang geeft, ter verbetering van zorg en vroegtijdige detectie van vaatlijden. | Mkb-innovati... | € 344.962 | 2023 | Details |
TIER - phoTonics dIagnosis hEpatocellular caRcinomaDit project ontwikkelt een prototype voor de validatie van een panel van 4 HCC-biomarkers, gericht op het verbeteren van de vroege diagnose van hepatocellulair carcinoom bij levercirrose. | Mkb-innovati... | € 197.979 | 2022 | Details |
Column with AC-EOF Induced Vortices for HPLC
The project aims to enhance blood analysis efficiency by integrating vortex mixing in HPLC columns, enabling faster separations for improved diagnostics, including diabetes monitoring.
The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale
Developing a non-invasive glucose monitoring device to improve diabetes management and prevent onset for over 2 billion people through EIC blended finance support.
Metal-Organic-Framework Kinetic Array for Diabetes Detection
This project aims to develop a novel sensor using metal-organic frameworks to selectively detect volatile organic compounds in breath for non-invasive diabetes diagnosis.
AFIDI
Het project ontwikkelt een betaalbare, minimaal invasieve CGM-sensor voor diabetespatiënten, die data veilig beheert en artsen toegang geeft, ter verbetering van zorg en vroegtijdige detectie van vaatlijden.
TIER - phoTonics dIagnosis hEpatocellular caRcinoma
Dit project ontwikkelt een prototype voor de validatie van een panel van 4 HCC-biomarkers, gericht op het verbeteren van de vroege diagnose van hepatocellulair carcinoom bij levercirrose.